Department of Central Intensive Care Unit, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.
J Clin Lab Anal. 2022 Apr;36(4):e24331. doi: 10.1002/jcla.24331. Epub 2022 Mar 9.
MALT1 is linked with multiple organic dysfunctions, inflammatory storm, and T helper (Th) cell differentiation. Herein, the current study aimed to investigate the correlation of peripheral blood mononuclear cell (PBMC) MALT1 with Th1 cells, Th17 cells, and prognosis of sepsis patients.
In general, 78 sepsis patients and 40 health controls (HCs) were enrolled. MALT1 expression was detected in PBMCs from all subjects by RT-qPCR. Besides, Th1 and Th17 cells were measured in PBMCs from sepsis patients by flow cytometry; interleukin 17A (IL-17A) and interferon gamma (IFN-γ) were determined in serum from sepsis patients by ELISA.
MALT1 expression was higher in sepsis patients than HCs (p < 0.001). MALT1 expression was positively correlated with Th17 cells (r = 0.291, p = 0.038) and IL-17A (r = 0.383, p = 0.001), but not with Th1 cells (r = 0.204, p = 0.151) or IFN-γ (r = 0.175, p = 0.125) in sepsis patients. MALT1 expression was positively correlated with APACHE II score (r = 0.275, p = 0.015), C-reactive protein (CRP) (r = 0.257, p = 0.023), and sequential organ failure assessment (SOFA) score (r = 0.306, p = 0.006) (MALT1 expression was positively correlated with SOFA respiratory system score (r = 0.348, p = 0.002), and SOFA liver score (r = 0.260, p = 0.021), but not with SOFA scores in nervous system, cardio vascular system, coagulation, and renal system (all p > 0.05)). MALT1 expression (p = 0.010), Th1 cells (p = 0.010), Th17 cells (p = 0.038), and IL-17A (p = 0.012), except for IFN-γ (p = 0.102), elevated in sepsis deaths compared with sepsis survivors.
PBMC MALT1 is highly expressed in sepsis patients with its overexpression associated with multiple organic dysfunctions, elevated Th17 cells, and increased mortality risk.
MALT1 与多种器官功能障碍、炎症风暴和辅助性 T 细胞(Th)分化有关。本研究旨在探讨外周血单个核细胞(PBMC)MALT1 与 Th1 细胞、Th17 细胞和脓毒症患者预后的相关性。
共纳入 78 例脓毒症患者和 40 例健康对照者(HCs)。采用 RT-qPCR 检测所有受试者 PBMC 中的 MALT1 表达。此外,采用流式细胞术检测脓毒症患者 PBMC 中的 Th1 和 Th17 细胞;采用 ELISA 法检测脓毒症患者血清中白细胞介素 17A(IL-17A)和干扰素 γ(IFN-γ)的含量。
脓毒症患者的 MALT1 表达高于 HCs(p<0.001)。MALT1 表达与 Th17 细胞(r=0.291,p=0.038)和 IL-17A(r=0.383,p=0.001)呈正相关,但与 Th1 细胞(r=0.204,p=0.151)或 IFN-γ(r=0.175,p=0.125)无关。MALT1 表达与急性生理与慢性健康状况评分系统 II 评分(r=0.275,p=0.015)、C 反应蛋白(CRP)(r=0.257,p=0.023)和序贯器官衰竭评估(SOFA)评分(r=0.306,p=0.006)呈正相关(MALT1 表达与 SOFA 呼吸系统评分(r=0.348,p=0.002)和 SOFA 肝脏评分(r=0.260,p=0.021)呈正相关,与神经系统、心血管系统、凝血和肾脏系统的 SOFA 评分无关(均 p>0.05))。MALT1 表达(p=0.010)、Th1 细胞(p=0.010)、Th17 细胞(p=0.038)和 IL-17A(p=0.012),除 IFN-γ(p=0.102)外,在脓毒症死亡患者中均高于存活患者。
脓毒症患者的 PBMC MALT1 表达水平升高,其过度表达与多种器官功能障碍、Th17 细胞升高和死亡风险增加有关。